Stay updated on PHA-022121 Dose Study for Acute Angioedema Clinical Trial

Sign up to get notified when there's something new on the PHA-022121 Dose Study for Acute Angioedema Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PHA-022121 Dose Study for Acute Angioedema Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    An additional version entry appears in the Record History page for NCT04618211; there are no substantive changes to the study content, status, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T01:12:45.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    34 days ago
    Change Detected
    Summary
    Summary of changes: Added a government-operating-status notice and a new study-related section with dates and outcomes, plus a new revision tag (v3.2.0). Removed the older revision tag (v3.1.0).
    Difference
    12%
    Check dated 2025-10-05T10:11:01.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.
    Difference
    0.2%
    Check dated 2025-09-28T03:15:52.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Update to v3.0.2; removed the 'Back to Top' link, with no other substantive changes.
    Difference
    0.6%
    Check dated 2025-09-13T16:59:08.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.
    Difference
    0.6%
    Check dated 2025-09-06T14:28:49.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has added a facility name and location details, which are crucial for users seeking specific information about the study. Additionally, several study status updates have been included, indicating ongoing research activities.
    Difference
    46%
    Check dated 2025-08-30T11:18:08.000Z thumbnail image

Stay in the know with updates to PHA-022121 Dose Study for Acute Angioedema Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PHA-022121 Dose Study for Acute Angioedema Clinical Trial page.